The ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media is a research paper published in Frontiers in Genetics (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
BLRD VA
Grant: IK6 BX005224
NIDCD NIH HHS
Grant: R01 DC012595
NIDCD NIH HHS
Grant: R01 DC000129
National Institutes of Health
Grant: 5R01DC012595-10
Innovative therapy for diseases of the middle ear
National Institutes of Health
Grant: 5R01DC000129-31
Middle Ear Response in Otitis Media
National Institute on Deafness and Other Communication Disorders U.S. Department of Veterans Affairs
FWCI
0.54
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
ECRG4 IN ACUTE OTITIS MEDIA